HYBRID EVENT: You can participate in person at Baltimore, Maryland, USA or Virtually from your home or work.

8th Edition of Nursing World Conference

October 17-19, 2024 | Baltimore, USA

October 17 -19, 2024 | Baltimore, USA
NWC 2017

Nicole Marie Candiff Llorens

Speaker at Nursing World Conference 2017 - Nicole Marie Candiff Llorens
Tulane University Hospital, United States
Title : Care of the patient with idiopathic pulmonary fibrosis resolving the mystery


I PF stands for Idiopathic Pulmonary Fibrosis, a rare condition that affects 14 - 43 people per 100,000, with a total of approximately 3 million patients worldwide. The lung tissue of someone with IPF becomes thickened, stiff and scarred. Fibrosis is the medical term for this scarring. The tiny air sacs (known as alveoli) and blood vessels of the lungs are responsible for providing the oxygen that every part of the body needs the information to be presented in regard to IPF will 1. Pathophysiology, prevalence and prognosis 2. Clinical features and diagnosis of IPF, 3. Recognizing IPF in clinical practice and 4. Patient Management.

Audience Take Away:

• It will help individuals to understand the importance of early identification and early referral with patients with IPF.

• Most patients with IPF experience breathlessness, which may initially be only on exertion, and cough, with or without sputum, is also common. Over time, there is a progressive decline in lung function, reduced quality of life and, ultimately, death.

• Prognosis is difficult to estimate at the time of diagnosis. When deterioration occurs, it can be rapid. Median survival for IPF from diagnosis in the world is approximately 3 years, and only about 20% of people will survive for more than 5 years.1 The likelihood for rapid deterioration and the detrimental impact of that on quality of life means that early diagnosis and appropriate management is vital.

• Clinical experience suggests that patients with IPF often present quite late in the disease course having had symptoms for many months/years prior to diagnosis. They have often first been misdiagnosed with other more common respiratory diseases like asthma or COPD before an IPF diagnosis is reached. Thus, for some, the potential of starting therapy early to prevent lung function decline is lost. Early recognition is key.


I am a advanced practice with a specialty in oncology. I have worked oncology for over 35 years working In surgical oncology, medical oncology, radiation oncology and palliative/palliative care. My goal is to give quality holistic care working in partnership with patients/ families in response to their needs. I have a been a advanced practice nurse for six years. I see nursing as my ministry. I am a recent lung transplant in Feb 2016 as a result of IPF. I am to have the opportunity to speak in nurses from the perspective as a patient and a provider. I AM A SURVIVIOR. Many nurses have no idea what IPF is and how to care for these patients .Early recognition is key.